Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant

References

• Jafari M, Moghaddam Pour M, Taghizadeh M, et al. Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens. Artif Cells Nanomed Biotechnol. 2017;45:84–89.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang S, Li Z, et al. Construction of a stable w/o nano-emulsion as a potential adjuvant for foot and mouth disease virus vaccine. Artif Cells Nanomed Biotechnol. 2017;45:897–906.
   PubMed Web of Science ®Google Scholar
• Amini Y, Moradi B, Fasihi-Ramandi M. Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis. Artif Cells Nanomed Biotechnol. 2017;45:1331–1335.
   PubMed Web of Science ®Google Scholar
• Mangal S, Pawar D, Agrawal U, et al. Evaluation of mucoadhesive carrier adjuvant: toward an oral anthrax vaccine. Artif Cells Nanomed Biotechnol. 2014;42:47–57.
   PubMed Web of Science ®Google Scholar
• Reed SG, Bertholet S, Coler RN, et al. New horizons in adjuvants for vaccine development. Trends Immunol. 2009;30:23–32.
   PubMed Web of Science ®Google Scholar
• Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol. 2004;82:488.
   PubMed Web of Science ®Google Scholar
• Lugade AA, Bharali DJ, Pradhan V, et al. Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity. Nanomedicine. 2013;9:923–934.
   PubMed Web of Science ®Google Scholar
• Dewangan HK, Pandey T, Singh S. Nanovaccine for immunotherapy and reduced hepatitis-B virus in humanized model. Artif Cells Nanomed Biotechnol. 2017 [1–10]. doi: https://doi.org/10.1080/21691401.2017.1408118
   Google Scholar
• Fakharzadeh S, Kalanaky S, Hafizi M, et al. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine. Vaccine. 2013;31:2591–2597.
   PubMed Web of Science ®Google Scholar
• Nejati-Koshki K, Mortazavi Y, Pilehvar-Soltanahmadi Y, et al. An update on application of nanotechnology and stem cells in spinal cord injury regeneration. Biomed Pharmacother. 2017;90:85–92.
   PubMed Web of Science ®Google Scholar
• Mohammadian F, Abhari A, Dariushnejad H, et al. Effects of chrysin-PLGA-PEG nanoparticles on proliferation and gene expression of miRNAs in gastric cancer cell line. Iran J Cancer Prev. 2016;9:1–8.
   Web of Science ®Google Scholar
• Mohammadian F, Pilehvar-Soltanahmadi Y, Zarghami F, et al. Upregulation of miR-9 and Let-7a by nanoencapsulated chrysin in gastric cancer cells. Artif Cells Nanomed Biotechnol. 2017;45:1201–1206.
   PubMed Web of Science ®Google Scholar
• Deldar Y, Pilehvar-Soltanahmadi Y, Dadashpour M, et al. An in vitro examination of the antioxidant, cytoprotective and anti-inflammatory properties of chrysin-loaded nanofibrous mats for potential wound healing applications. Artif Cells Nanomed Biotechnol. 2017 [1–11]. doi: https://doi.org/10.1080/21691401.2017.1337022
   PubMed Web of Science ®Google Scholar
• Farajzadeh R, Pilehvar-Soltanahmadi Y, Dadashpour M, et al. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. Artif Cells Nanomed Biotechnol. 2017 [1–9]. doi: https://doi.org/10.1080/21691401.2017.1347879
   PubMed Web of Science ®Google Scholar
• Vasou A, Sultanoglu N, Goodbourn S, et al. Targeting pattern recognition receptors (PRR) for vaccine adjuvantation: from synthetic PRR agonists to the potential of defective interfering particles of viruses. Viruses. 2017;9:186.
   PubMed Web of Science ®Google Scholar
• Khanmohammadi M, Elmizadeh H, Ghasemi K. Investigation of size and morphology of chitosan nanoparticles used in drug delivery system employing chemometric technique. Iran J Pharm Res. 2015;14:665.
   PubMed Web of Science ®Google Scholar
• Hembram KC, Prabha S, Chandra R, et al. Advances in preparation and characterization of chitosan nanoparticles for therapeutics. Artif Cells Nanomedicine Biotechnol. 2016;44:305–314.
   PubMed Web of Science ®Google Scholar
• Al-So'od K. Interaction between low molecular weight chitosan and some types of drugs and insulin. Asian J Chem. 2012;24:3785–3790.
   Google Scholar
• Başak E, Aydemir T. Immobilization of catalase on chitosan and amino acid-modified chitosan beads. Artif Cells Nanomedicine Biotechnol. 2013;41:269–275.
   PubMed Web of Science ®Google Scholar
• Shilakari Asthana G, Asthana A, Kohli DV, et al. Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting. BioMed Res Int. 2014;2014:1–17.
   Web of Science ®Google Scholar
• Gomathi T, Sudha P, Florence JAK, et al. Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method. Int J Biol Macromol. 2017;104:1820–1832.
   PubMed Web of Science ®Google Scholar
• Amirsaadat S, Pilehvar-Soltanahmadi Y, Zarghami F, et al. Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells. Artif Cells Nanomedicine Biotechnol. 2017;45:1649–1656.
   PubMed Web of Science ®Google Scholar
• Farajzadeh R, Zarghami N, Serati-Nouri H, et al. Macrophage repolarization using CD44-targeting hyaluronic acid–polylactide nanoparticles containing curcumin. Artif Cells Nanomed Biotechnol. 2017 [1–9]. doi: https://doi.org/10.1080/21691401.2017.1408116
   Google Scholar
• Esfandiarpour-Boroujeni S, Bagheri-Khoulenjani S, Mirzadeh H, et al. Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application. Carbohydr Polym. 2017;168:14–21.
   PubMed Web of Science ®Google Scholar
• Raja Azalea D, Mohambed M, Joji S, et al. Design and evaluation of chitosan nanoparticles as novel drug carriers for the delivery of donepezil. Iran J Pharm Res. 2012;8:155–164.
   Google Scholar
• Rezayat M. Preparation, characterization and stability investigation of chitosan nanoparticles loaded with the Echis carinatus snake venom as a novel delivery system. Arch Razi Institute 2015;70:269–277.
   Google Scholar
• Mizukami T, Masumi A, Momose H, et al. An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan. Biologicals. 2009;37:8–17.
   PubMed Web of Science ®Google Scholar
• Bhumkar DR, Pokharkar VB. Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech. 2006;7:E138–EE43.
   PubMed Web of Science ®Google Scholar
• Li P, Dai YN, Zhang JP, et al. Chitosan-alginate nanoparticles as a novel drug delivery system for nifedipine. Int J Biomed Sci. 2008;4:221.
   PubMedGoogle Scholar
• Arora S, Lal S, Kumar S, et al. Comparative degradation kinetic studies of three biopolymers: chitin, chitosan and cellulose. Arch Appl Sci Res. 2011;3:188–201.
   Google Scholar
• Yao W, Jiao Y, Luo J, et al. Practical synthesis and characterization of mannose-modified chitosan. Int J Biol Macromol. 2012;50:821–825.
   PubMed Web of Science ®Google Scholar
• Ahmed TA, Aljaeid BM. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther. 2016;10:483.
   PubMed Web of Science ®Google Scholar
• Grenha A. Chitosan nanoparticles: a survey of preparation methods. J Drug Target. 2012;20:291–300.
   PubMed Web of Science ®Google Scholar
• Shukla S, Myers JT, Woods SE, et al. Plant viral nanoparticles-based HER2 vaccine: immune response influenced by differential transport, localization and cellular interactions of particulate carriers. Biomaterials. 2017;121:15–27.
   PubMed Web of Science ®Google Scholar
• Ho HN, Tran TH, Tran TB, et al. Optimization and characterization of artesunate-loaded chitosan-decorated poly (D, L-lactide-co-glycolide) acid nanoparticles. J Nanomater. 2015;16:383.
   Google Scholar
• Kim TH, Jin H, Kim HW, et al. Mannosylated chitosan nanoparticle–based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther. 2006;5:1723–1732.
   PubMed Web of Science ®Google Scholar
• Bhattarai N, Ramay HR, Chou SH, et al. Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery. Int J Nanomedicine. 2006;1:181.
   PubMed Web of Science ®Google Scholar
• Aydin R, Pulat M. 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics. J Nanomater. 2012;2012:42.
   Web of Science ®Google Scholar
• Xue M, Hu S, Lu Y, et al. Development of chitosan nanoparticles as drug delivery system for a prototype capsid inhibitor. Int J Pharm. 2015;495:771–782.
   PubMed Web of Science ®Google Scholar
• Mobasseri R, Karimi M, Tian L, et al. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity. Mater Sci Eng C. 2017;74:413–421.
   PubMed Web of Science ®Google Scholar
• Parida UK, Rout N, Bindhani BK. In vitro properties of chitosan nanoparticles induce apoptosis in human lymphoma SUDHL-4 cell line. Adv Biosci Biotechnol. 2013;4:1118.
   Google Scholar
• Peng Y, Yao W, Wang B, et al. Mannosylated chitosan nanoparticles based macrophage-targeting gene delivery system enhanced cellular uptake and improved transfection efficiency. J Nanosci Nanotechnol. 2015;15:2619–2627.
   PubMed Web of Science ®Google Scholar